Navigating the maze of treatment strategies for RA-ILD: Insights and innovations for better patient outcomes
Int J Rheum Dis
.
2023 Oct;26(10):1899-1903.
doi: 10.1111/1756-185X.14830.
Authors
Po-Cheng Shih
1
2
3
,
Shu-Hao Chang
4
,
An-Ping Huo
3
5
,
James Cheng-Chung Wei
3
5
6
Affiliations
1
Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan.
2
Department of Allergy, Immunology & Rheumatology, Changhua Christian Hospital, Changhua, Taiwan.
3
Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
4
Division of Pulmonary Medicine, Department of Internal Medicine, Cheng Ching Hospital, Taichung, Taiwan.
5
Department of Allergy, Immunology & Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan.
6
Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan.
PMID:
37807614
DOI:
10.1111/1756-185X.14830
No abstract available
Keywords:
interstitial lung disease; management; precision medicine; rheumatoid arthritis.
Publication types
Editorial
MeSH terms
Antirheumatic Agents* / therapeutic use
Arthritis, Rheumatoid* / diagnosis
Arthritis, Rheumatoid* / drug therapy
Humans
Substances
Antirheumatic Agents